SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,095 | -35.7% | 89,947 | -1.0% | 0.00% | – |
| Q2 2023 | $541,293 | +136.4% | 90,821 | +29.7% | 0.00% | – |
| Q1 2023 | $228,929 | -14.2% | 70,009 | +3.6% | 0.00% | – |
| Q4 2022 | $266,886 | -34.3% | 67,566 | 0.0% | 0.00% | – |
| Q3 2022 | $406,000 | -3.8% | 67,566 | +2.8% | 0.00% | – |
| Q2 2022 | $422,000 | -8.5% | 65,702 | +17.9% | 0.00% | – |
| Q1 2022 | $461,000 | +59.0% | 55,718 | +198.0% | 0.00% | – |
| Q4 2021 | $290,000 | +34.9% | 18,698 | +95.6% | 0.00% | – |
| Q3 2021 | $215,000 | +216.2% | 9,558 | +176.1% | 0.00% | – |
| Q2 2021 | $68,000 | -38.7% | 3,462 | +4.5% | 0.00% | – |
| Q1 2021 | $111,000 | – | 3,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |